In vitro-Diagnostics and BioanalysisJune 5 – 6 · 2013 · Potsdam · GERMANY
Programme
5th BERLIN-BRANDENBURGTECHNOLOGY FORUM
Supported by:
Organized by:
In cooperation with:
5th Berlin-Brandenburg Technology Forum
In vitro-Diagnostics and Bioanalysis
5th Berlin-Brandenburg Technology Forum
In vitro-Diagnostics and Bioanalysis
Scientific LecturesThe latest trends in the deve-lopment of diagnostics
ExhibitionShowcasing products,services and technologies
PartneringPre-scheduled one-to-one meetings for companies and research institutes
Company Presentations Presentations by innovative diagnostics companies
Impressions
5th Berlin-Brandenburg Technology Forum
In vitro-Diagnostics and Bioanalysis
Your partner for next Generation in vitro-Diagnostics
Being the largest life sciences-spot, about 100 diag-nostics companies and a significant number of well-known research institutes cover the full range of the diagnostics value chain in the German Capital Region
– from biomarker identification to clinical research, production and services.
The Berlin-Brandenburg region develops solutions for next gene-
ration in vitro-diagnostics and bioanalysis, such as sensor-actor-
molecules and autonomous biosensors, genome, proteome- and
glycan-based multiplex analytics (microarray and bead technolo-
gies) and metabolomics platforms for new biomarker strategies.
Berlin-Brandenburg offers excellent conditions for implementing
clinical validation studies. Being Germany’s most diversified hos-
pital landscape with the Charité – Universitätsmedizin Berlin, it
has access to patient cohorts of urban and rural populations of
about 180 ethnicities, covering all medical indications. Custo-
mers from research and industry have access to advanced bioban-
king infrastructures.
June 5-6, 2013 · Potsdam 5th
Berlin-Brandenburg Technology Forum “In vitro-Diagnostics and Bioanalysis”
Facing the economical and medical challenges, new biomarkers and innovative diagnostics become more and more significant for the health care systems of the future. As basis for individualized therapy decisions, predictive testing is one of the key drivers for the next generation of in vitro-diagnostics.
For many years now, the Berlin-Brandenburg Technology Forum
on „In vitro-Diagnostics and Bioanalysis“ provides an excellent
platform for initiating a sustainable dialogue between fundamen-
tal research, industrial development and clinical application. The
5th Technology Forum focuses on mass spectrometry, protein ar-
rays and aptamer-based sensors.
A specially designed partnering event for diagnostics companies
and research institutes facilitates to meet new co-operation part-
ners from Europe and aims at fostering and encouraging possible
growth opportunities. Participants will have the opportunity to
join a guided science tour in Potsdam on June 5th.
This June, the Technology Forum 2013 will be once again the
place to be for discussing new trends and topics in the field of in
vitro-diagnostics.
5th Berlin-Brandenburg Technology Forum
In vitro-Diagnostics and Bioanalysis
5th Berlin-Brandenburg Technology Forum
In vitro-Diagnostics and Bioanalysis5th Berlin-Brandenburg Technology Forum
In vitro-Diagnostics and Bioanalysis
Programme
Wednesday, June 5
13:00—14:30 Workshop
Impact of the future IVD regulation on SMEs
in Europe—workshop with European experts
organized by EDCA”
(by separate invitation)
15:00—17:00 Guided Science Tour to Potsdam-Golm
Science Park
Leading international research from
biotechnology to gravitational physics, training for
young researchers and research-based production
combine to make this science park a location with
extraordinary potential for innovation, guided
tour of Fraunhofer Institute for Biomedical
Engineering IBMT included, tour starts at
conference venue.
15:00—17:30 EDCA Board Meeting
18:00—20:00 Welcome Reception
(by separate invitation)
Welcome Address
Kai Bindseil · Healthcare Industries Cluster
Manager Berlin-Brandenburg – HealthCapital
Biomarker strategy at Bayer AG
Ulrich Zügel · Bayer Pharma AG · Berlin · Germany
Life sciences in Canada: Changing paradigms
in diagnostics and treatment
Pierre Bélanger · Sherbrooke Innopole
Sherbrooke · Quebec
Programme
Thursday, June 6
Industrial Exhibition (9:00—17:00)About 25 SME showcase their latest products and
technologies
Partnering (9:00–17:00)
Welcome Addresses09:00 Günter Stock · Healthcare Industries Cluster
Spokesman Berlin-Brandenburg—HealthCapital
and President of the Berlin-Brandenburg Academy
of Sciences and Humanities (BBAW)
09:15 Basic research in Berlin-Brandenburg and
diagnostics development
Peter Seeberger · Max Planck Institute of Colloids and
Interfaces (MPIKG) · Berlin · Germany
09:30 Key Note
Mass spectrometry and its impact on next generation
diagnostics development
Matthias Mann · Max Planck Institute of Biochemistry
Martinsried · Germany
Session ITechnology DevelopmentChair: Frank Bier · Fraunhofer Insitute for Biomedical
Engineering (IBMT)
10:10 Targeted proteomics and imaging mass spectrometry
Edwin de Pauw · Liège University · Liège · Belgium
10:40 Coffee
5th Berlin-Brandenburg Technology Forum
In vitro-Diagnostics and Bioanalysis
5th Berlin-Brandenburg Technology Forum
In vitro-Diagnostics and Bioanalysis
11:00 DNA array to protein array technology (DAPA) for
applications in proteomics
Ronny Schmidt · Babraham Institute · Cambridge
United Kingdom
11:30 Design guidelines for the commercially successful
production of lab-on-a-chip consumables
Ralf Himmelreich · Institut für Mikrotechnik Mainz GmbH
Germany
12:00 The advantages of an aptamer based companion
diagnostic strategy
Gregory Penner · NeoVentures Biotechnology Inc.
London · Canada
12:30 Lunch
Session IIBiomarker and Clinical ResearchChair: Günter Peine · ZMDB
Rudolf Tauber · Charité – Universitätsmedizin Berlin
13:15 Mass cytometry based single cell analysis for
immunodiagnostics of the future
Andreas Thiel · BCRT/Charité Berlin · Germany
13:35 Metabolic biomarkers—an enabling new tool for the
development of drugs and diagnostics
Philipp Schatz · Metanomics Health GmbH · Berlin
Germany
13:55 Steroid analysis—clinical and research applications
Nils Krone · University of Birmingham · Birmingham
United Kingdom
14:25 Quantitative mass spectrometry of peptides and
proteins, a new era in clinical biomarker detection
Sylvain Lehmann · Universitaire de Montpellier
Montpellier · France
14:55 Identification of autoantibody biomarkers for colon
and prostate cancer screening assays using protein
microarrays
Johanna Fuchs-Luna · AIT Austrian Institute of Technology
GmbH · Vienna · Austria
15:25 Multiparametric protein detection in laboratory
medicine—technology and applications
Masood Kamali-Moghaddam · Science for Life Laboratory
Uppsala · Sweden
15:55 Expanding the quantitative targeted mass
spectrometry facility at the Necker-Enfants malades
University Hospital: The upcoming change in clinical
diagnosis
Sylvia Sanquer · Necker-Enfants malades University
Hospital · Paris · France
16:15 Coffee
Session IIIIndustrial Development—Medical ApplicationChair: Stefan von Senger und Etterlin · ZukunftsAgentur
Brandenburg
16:35 International Company Presentations
17:35 End of programme
Guided City Tour (18:00—19:30)
This tour presents the cultural heart of Potsdam-Sanssouci
palace and park, followed by dinner at an historical
location guided tour is free of charge, dinner is to be paid
individually.
5th Berlin-Brandenburg Technology Forum
In vitro-Diagnostics and Bioanalysis
Participation in the Technology Forum is free of charge.
The fee for the partnering event amounts € 50.00 (incl. VAT).
Prior registration is requested at
www.zmdb.de/technologyforum2013/
(Scientific Lectures and Guided Tours)
www.b2match.eu/tech-forum5/
(Partnering Event)
Your benefits from the Partnering Event:
k Showcase your profile to other participants of the event
k Organize yourself individual pre-scheduled one-to-one
meetings with the help of a web-based online tool
k Meet potential business, technological or research partners
for future co-operation
k Develop partnerships leading to technological and
commercial collaboration
k Establish cross-border contacts for long-term business
relationships
Whom you will meet:
k Developers and producers of in vitro-diagnostics
k Service providers
k Suppliers
k Distributors
k Research institutions
The earlier you submit your collaboration profile, the more it will be noticed.
5th Berlin-Brandenburg Technology Forum
In vitro-Diagnostics and Bioanalysis
The European Diagnostic Clusters Alliance unites around 400 diagnostic companies in 7 EU countries and is fully supporting the event, making it a real European quality brand for SME-directed diagnostic partnering.
EDCA unites the strengths of Europe’s diagnostics clusters for scientific excellence and economic growth!
Main Objectives » Facilitating the growth of European SMEs in medical diagnostics » Promoting cooperations between diagnostic clusters » Internationalizing of diagnostics development by European collaborative projects
Biocat Katalonien Barcelona ESBioWales Swansea GBBioWin Wallonia Liège BEEuromediag Languedoc-Roussillon Montpellier FRLife Science Cluster Krakau PLLyonbiopôle Lyon FRNexxus East of Scotland Edinburgh GBOxfordshire Bioscience Network Oxford GBUppsalaBio Uppsala SEZMDB/TSB Berlin-Brandenburg DE
Contact
TSB Innovationsagentur Berlin GmbH
Zentrum für Molekulare Diagnostik und Bioanalytik (ZMDB)
Dr. Günter Peine
www.zmdb.de
Venue
Schiffbauergasse · Schinkelhalle
14467 Potsdam · Germany
Directions: www.schiffbauergasse.de/index.php?b=3&p=55
(English version available)
Further Information
www.zmdb.de/technologyforum2013/
The Center for Molecular Diagnostics and Bioanalysis (ZMDB) is a Flagship Project of the Joint Innovation Strategy Berlin-Brandenburg at the TSB Innovationsagentur Berlin GmbH. The ZMDB is funded by the states of Berlin and Brandenburg and co-financed by the European Regional Development Fund (ERDF) of the European Union. An investment in your future!